Pleo Ex - 60681-1005-1 - (candida albicans, candida parapsilosis and penicillium roqueforti)

Alphabetical Index


Drug Information of Pleo Ex

Product NDC: 60681-1005
Proprietary Name: Pleo Ex
Non Proprietary Name: candida albicans, candida parapsilosis and penicillium roqueforti
Active Ingredient(s): 5; 5; 5    [HP_X]/mL; [HP_X]/mL; [HP_X]/mL & nbsp;   candida albicans, candida parapsilosis and penicillium roqueforti
Administration Route(s): ORAL
Dosage Form(s): LIQUID
Coding System: National Drug Codes(NDC)

Labeler Information of Pleo Ex

Product NDC: 60681-1005
Labeler Name: Sanum Kehlbeck GmbH & Co. KG
Product Type: HUMAN OTC DRUG
FDA Application Number:
Marketing Category: UNAPPROVED HOMEOPATHIC
Start Marketing Date: 19980119

Package Information of Pleo Ex

Package NDC: 60681-1005-1
Package Description: 10 VIAL, GLASS in 1 CARTON (60681-1005-1) > 1 mL in 1 VIAL, GLASS

NDC Information of Pleo Ex

NDC Code 60681-1005-1
Proprietary Name Pleo Ex
Package Description 10 VIAL, GLASS in 1 CARTON (60681-1005-1) > 1 mL in 1 VIAL, GLASS
Product NDC 60681-1005
Product Type Name HUMAN OTC DRUG
Non Proprietary Name candida albicans, candida parapsilosis and penicillium roqueforti
Dosage Form Name LIQUID
Route Name ORAL
Start Marketing Date 19980119
Marketing Category Name UNAPPROVED HOMEOPATHIC
Labeler Name Sanum Kehlbeck GmbH & Co. KG
Substance Name CANDIDA ALBICANS; CANDIDA PARAPSILOSIS; PENICILLIUM ROQUEFORTI
Strength Number 5; 5; 5
Strength Unit [HP_X]/mL; [HP_X]/mL; [HP_X]/mL
Pharmaceutical Classes

Complete Information of Pleo Ex


General Information